这是描述信息
Location:
Homepage
/
/
Fosun Pharma: The first batch of mRNA COVID-19 vaccine, Fubitai, arrives in Taiwan

Fosun Pharma: The first batch of mRNA COVID-19 vaccine, Fubitai, arrives in Taiwan

  • Categories:Trade info
  • Author:
  • Origin:
  • Time of issue:2021-09-02
  • Views:0

(Summary description)

Fosun Pharma: The first batch of mRNA COVID-19 vaccine, Fubitai, arrives in Taiwan

(Summary description)

  • Categories:Trade info
  • Author:
  • Origin:
  • Time of issue:2021-09-02
  • Views:0
Information

(Shanghai, China, September 2, 2021) Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharmaceutical" or "Group", stock code: 600196.SH, 02196.HK) announced that on September 2, Fosun Pharma supplied the first batch of mRNA new crown vaccine Fubitai (ie BNT162b2) produced by BioNTech in Taiwan from Europe to Taoyuan Airport in Taiwan, and the first batch arrived at 932,000 doses. The vaccine will be donated by private organizations in Taiwan for inoculation of Taiwan compatriots. It is suitable for active immunization of teenagers and adults over 12 years old to prevent diseases caused by new coronavirus infection.

Scan the QR code to read on your phone

Copyright hongqipharma.com All rights reserved     Powered by:300.cn Shenyang    辽icp备12005917号    (辽)-非经营性-2018-0012 

Add:Shenyang Hunnan New District envelope 6th Street    Tel:024-23786268-8012  Fax:024-23786263